Viewing nowCandesartan Tablets 8 mg (Candesartan Cilexetil)
Candesartan Cilexetil 8mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.

MFDS item code 201905790 · Approved 2019.08.14 · Insurance code 657307770
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
This medication is used to control blood pressure in patients with essential hypertension. It is also used as an adjunct treatment for patients with heart failure who have impaired left ventricular systolic function, especially when the use of ACE inhibitors is inadequate or not well tolerated. Through this effect, it helps improve heart function and prevent the worsening of symptoms.
This medicine should be taken at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, another treatment should be considered. The maximum effect is reached within 4 weeks after starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: For patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those undergoing hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into consideration, up to a maximum of 32 mg once daily. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.
1. Essential hypertension 6) Pediatric patients: The safety and efficacy in adolescents and children aged 18 years or younger have not been established. 2. Heart failure 3) Pediatric patients: The safety and efficacy in adolescents and children aged 18 years or younger have not been established.
This medication can cause serious harm to the fetus and newborn during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. This drug should not be used in specific patient populations such as pregnant women, nursing mothers, patients with severe liver impairment, or hereditary angioedema patients. Caution should be exercised when administering to elderly persons or patients with hyperkalemia, liver impairment, or heart disease, and blood pressure and kidney function should be regularly monitored. This medication may cause side effects such as dizziness, back pain, and respiratory infections. In heart failure patients, adverse reactions such as hypotension or kidney function impairment may occur. It is important to regularly check serum potassium and creatinine levels to prevent hyperkalemia or worsening kidney function. Caution is particularly needed when this drug is combined with potassium-sparing diuretics, potassium supplements, or lithium preparations, as the risk of side effects increases. It is advisable to stop the medication 24 hours before surgical procedures, and blood pressure changes should be closely monitored in hemodialysis patients. Because dizziness or malaise may occur, caution is needed when driving or operating machinery. The safety and efficacy in children and adolescents under 18 years of age have not been established, and it is preferable not to use it in this age group. In case of overdose, symptoms such as hypotension, dizziness, and tachycardia may occur, and prompt appropriate treatment and monitoring are required. Keep out of reach of children and do not transfer to other containers for safety.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture; therefore, it should be stored in a tightly closed container. It is advisable to maintain a storage temperature between 1 degree and 30 degrees Celsius. This way, the medication's effectiveness can be preserved for a long time.
Light pink tablets with convex faces on both sides.
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCandesartan Cilexetil 8mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.

Candesartan Cilexetil 16mg
Tablet · Prescription medication
Yuhans Chemical Co., Ltd.

Candesartan Cilexetil 8mg
Tablet · Prescription medication
Yuhan Corporation

Candesartan Cilexetil 32mg
Tablet · Prescription medication
DKSH Korea Co., Ltd.

Candesartan Cilexetil 8mg
Tablet · Prescription medication
Jong Kun Dang Co., Ltd.

Candesartan Cilexetil 16mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Candesartan Cilexetil 16mg
Tablet · Prescription medication
Ajou Pharmaceutical Co., Ltd.

Candesartan Cilexetil 16mg
Tablet · Prescription medication
ShinPoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.